BR112017006402A2 - métodos para o tratamento de peri-implantite - Google Patents

métodos para o tratamento de peri-implantite

Info

Publication number
BR112017006402A2
BR112017006402A2 BR112017006402A BR112017006402A BR112017006402A2 BR 112017006402 A2 BR112017006402 A2 BR 112017006402A2 BR 112017006402 A BR112017006402 A BR 112017006402A BR 112017006402 A BR112017006402 A BR 112017006402A BR 112017006402 A2 BR112017006402 A2 BR 112017006402A2
Authority
BR
Brazil
Prior art keywords
implant
peri
bone
methods
implantitis
Prior art date
Application number
BR112017006402A
Other languages
English (en)
Other versions
BR112017006402B1 (pt
Inventor
Emanuel Noam
Original Assignee
Polypid Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polypid Ltd filed Critical Polypid Ltd
Publication of BR112017006402A2 publication Critical patent/BR112017006402A2/pt
Publication of BR112017006402B1 publication Critical patent/BR112017006402B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/50—Preparations specially adapted for dental root treatment
    • A61K6/58—Preparations specially adapted for dental root treatment specially adapted for dental implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849—Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/849—Preparations for artificial teeth, for filling teeth or for capping teeth comprising inorganic cements
    • A61K6/864—Phosphate cements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/891—Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymers & Plastics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

a presente invenção refere-se a composições farmacêuticas e métodos para o tratamento das doenças de peri-implante, particularmente doença peri-implantar caracterizada pela destruição da cresta do osso alveolar que apoia o implante. especificamente, o método compreende a etapa da aplicação a um osso de peri-implante que exibe reabsorção crestal uma composição farmacêutica 5 que compreende material de aumento ósseo biocompatível revestido com uma composição de matriz que fornece liberação prolongada e com controle de local de pelo menos um agente farmaceuticamente ativo no local da perda óssea.
BR112017006402-2A 2014-10-02 2015-09-27 uso de uma composição farmacêutica compreendendo um material de aumento ósseo biocompatível revestido com uma composição de matriz BR112017006402B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462059116P 2014-10-02 2014-10-02
US62/059,116 2014-10-02
PCT/IB2015/057410 WO2016051322A1 (en) 2014-10-02 2015-09-27 Methods for the treatment of peri-implantitis

Publications (2)

Publication Number Publication Date
BR112017006402A2 true BR112017006402A2 (pt) 2017-12-19
BR112017006402B1 BR112017006402B1 (pt) 2021-03-02

Family

ID=55629499

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017006402-2A BR112017006402B1 (pt) 2014-10-02 2015-09-27 uso de uma composição farmacêutica compreendendo um material de aumento ósseo biocompatível revestido com uma composição de matriz

Country Status (15)

Country Link
US (1) US10758639B2 (pt)
EP (1) EP3200749B1 (pt)
JP (1) JP2017531461A (pt)
KR (1) KR102466337B1 (pt)
CN (1) CN107072885B (pt)
AU (1) AU2015326429B2 (pt)
BR (1) BR112017006402B1 (pt)
CA (1) CA2961998C (pt)
EA (1) EA038147B1 (pt)
IL (1) IL251345B (pt)
MX (1) MX2017004319A (pt)
NZ (1) NZ729628A (pt)
PH (1) PH12017500570A1 (pt)
SG (1) SG11201702700UA (pt)
WO (1) WO2016051322A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110856702A (zh) * 2018-08-23 2020-03-03 上海利康消毒高科技有限公司 种植牙口腔护理凝胶及其制备方法
JP7402339B2 (ja) * 2019-12-04 2023-12-20 デイタム デンタル リミテッド 非外科的方法で歯周を治療するためのコラーゲン－ヒドロキシアパタイトデバイス
KR102439762B1 (ko) 2021-03-09 2022-09-02 주식회사 오라팜 임플란트 주위점막염 예방 및 치료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001518359A (ja) * 1997-10-07 2001-10-16 ドクトル．ハー．ツェー．ロベルト マシーズ スティフツング 外科用水硬セメント
CA2306562A1 (en) * 1997-10-07 1999-04-15 Dr. H. C. Robert Mathys Stiftung Hydraulic surgical cement
EP2143451A1 (en) 2008-07-11 2010-01-13 Nobel Biocare Services AG Bone implant application
CN104274866B (zh) 2008-07-14 2016-08-24 波利皮得有限公司 持续释放药物载体组合物
AU2010272167B2 (en) * 2009-07-14 2016-11-17 Polypid Ltd. Sustained-release drug carrier composition
NL1039169C2 (en) * 2011-11-15 2013-05-16 Kamosi Hoshang Peri-implant ultrasound debridement device (pius-dd).
JP6182213B2 (ja) 2012-08-02 2017-08-16 ポリピッド リミテッド 骨空洞および開放骨折の治療のための組成物および方法

Also Published As

Publication number Publication date
SG11201702700UA (en) 2017-04-27
EP3200749B1 (en) 2020-09-02
AU2015326429B2 (en) 2020-11-12
US20170246342A1 (en) 2017-08-31
US10758639B2 (en) 2020-09-01
CN107072885A (zh) 2017-08-18
EA038147B1 (ru) 2021-07-13
PH12017500570A1 (en) 2017-08-30
KR20170101890A (ko) 2017-09-06
CA2961998C (en) 2022-07-26
EP3200749A1 (en) 2017-08-09
IL251345B (en) 2021-05-31
EA201790382A1 (ru) 2017-08-31
WO2016051322A1 (en) 2016-04-07
CN107072885B (zh) 2021-08-17
IL251345A0 (en) 2017-05-29
AU2015326429A1 (en) 2017-03-23
CA2961998A1 (en) 2016-04-07
JP2017531461A (ja) 2017-10-26
MX2017004319A (es) 2017-05-19
BR112017006402B1 (pt) 2021-03-02
KR102466337B1 (ko) 2022-11-14
EP3200749A4 (en) 2018-05-23
NZ729628A (en) 2023-02-24

Similar Documents

Publication Publication Date Title
BR112016018008A2 (pt) Implante de osso
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
BR112017006406A2 (pt) composições e métodos para o tratamento e profilaxia de infecções de sítio cirúrgico
BR112017017448A2 (pt) métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho
BR112022011716A2 (pt) Plaquetas manipuladas para entrega alvejada de um agente terapêutico
CL2019002218A1 (es) Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
BR112017016084A2 (pt) composição e método para o tratamento da doença veno-oclusiva hepática
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
BRPI1015539A2 (pt) composições e métodos para tratamento de queimaduras
BR112017006402A2 (pt) métodos para o tratamento de peri-implantite
BR112015013539A2 (pt) composições de formação de cimento, cimentos monetita, implantes e métodos para a correção de defeitos de ossos
BR112017017346A2 (pt) implantes para esculpir, aumentar ou corrigir atributos faciais tais como o queixo
CL2018001548A1 (es) Tratamiento de colestasis intrahepática y enfermedades del hígado relacionadas
EA201591152A1 (ru) Аморфный карбонат кальция для ускоренного роста костной ткани
BR112012011672A2 (pt) implantes e métodos para a realização de aumento e preservação de gengivas e ossos.
EA201590049A1 (ru) Композиции и способы для лечения участков отсутствующей костной ткани и открытых переломов
CL2018000430A1 (es) Compuesto de hidroxitriazina y uso médico relacionado.
CL2017002006A1 (es) Implante dental para facilitar y estabilizar la implantacion.
PE20211599A1 (es) Administracion prolongada de lasmiditan por la noche para la prevencion de la migrana
BR112018000589A2 (pt) composição de tratamento de cabelo, método para o tratamento de cabelo e utilização de uma composição
BR112017015613A2 (pt) gel intestinal de levodopa e carbidopa e métodos de utilização
BR112016030728A2 (pt) método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença
BR112017023534A2 (pt) composição fungicida e método para controlar doenças de plantas
CO6620053A2 (es) Composición para el control de plagas
AR112844A1 (es) Composición de hidrogel a base de ácido hialurónico estabilizada farmacéuticamente y método de preparación de esta

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/09/2015, OBSERVADAS AS CONDICOES LEGAIS.